Nu Skin Enterprises Inc. (NUS) Stock
Fundamentals
Source: third-party data provider, as of October 14, 2026
Compare with NUS
Recent news

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
NUS

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
NUS

Nu Skin Enterprises Q2 Earnings Call Highlights
Nu Skin Enterprises Q2 Earnings Call Highlights
NUS

Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
NUS
Technical indicators
- RSI 14
- 62.88
- MACD 12/26/9
- 0.02
- EMA 9 of MACD
- -0.03
- MACD histogram
- 0.05
- SMA 50
- $4.79
- Price above SMA 50
- EMA 50
- $4.85
- Price above EMA 50
- SMA 200
- $6.73
- Price below SMA 200
- EMA 200
- $6.79
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst ratings
No analyst data available
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year
NUS

Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y
NUS

Nu Skin Enterprises Q2 Earnings Call Highlights
Nu Skin Enterprises Q2 Earnings Call Highlights
NUS

Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates
NUS

Nu Skin Enterprises Reports Second Quarter Results
Nu Skin Enterprises Reports Second Quarter Results
NUS

Nu Skin Enterprises Announces Quarterly Dividend
Nu Skin Enterprises Announces Quarterly Dividend
NUS

Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results
NUS

5 Undervalued Stocks With Attractive Price-to-Sales Ratios
5 Undervalued Stocks With Attractive Price-to-Sales Ratios
NUS

5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026
5 Beauty & Cosmetics Stocks to Buy for a Stable Portfolio in 2H 2026
NUS

Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
Nu Skin (NUS) Soars 6.9%: Is Further Upside Left in the Stock?
NUS
About Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Ryan S. Napierski | President, CEO & Director | 1974 |
| Mr. Steven J. Lund J.D. | Co-Founder & Executive Chairman of the Board | 1953 |
| Dr. Joseph Y. Chang Ph.D. | Executive VP, Chief Scientific Officer & Chair of Scientific Advisory Board | 1953 |
| Mr. Chayce David Clark | Executive VP, COO & Chief Legal Officer | 1983 |
| Ms. Chelsea Lantz | Chief Financial Officer | 1984 |
| Mr. Justin S. Keisel | Executive VP & President of Global Sales (Leave of Absence) | 1974 |
| Mr. Blake M. Roney | Founder | 1959 |
| Ms. Sandra N. Tillotson | Founder | 1957 |
| Mr. Joe Sueper | Senior VP & CTO | — |
| Mr. B.G. Hunt | VP of Treasurer, Investor Relations & Admin Services | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 14, 2026
Technical indicators
- RSI 14
- 62.88
- MACD 12/26/9
- 0.02
- EMA 9 of MACD
- -0.03
- MACD histogram
- 0.05
- SMA 50
- $4.79
- Price above SMA 50
- EMA 50
- $4.85
- Price above EMA 50
- SMA 200
- $6.73
- Price below SMA 200
- EMA 200
- $6.79
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of October 13, 2026. Technical data, not a recommendation.
Analyst views
No analyst data available
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -2.2 | +7.6 | +17.7 | |||||||||
| 2022 | -8.0 | -9.1 | +5.9 | -12.7 | +4.9 | -7.4 | -2.7 | -8.1 | -18.0 | +11.8 | +6.5 | +3.2 |
| 2023 | +1.5 | -10.0 | -3.4 | -2.4 | -16.8 | -1.2 | -12.4 | -19.7 | -11.6 | -8.5 | -8.6 | +10.6 |
| 2024 | -8.7 | -33.8 | +9.4 | -12.8 | +12.8 | -22.1 | +0.0 | |||||
| 2026 | -14.9 | -9.9 | -0.8 | -19.5 | -6.2 | -1.1 | -9.1 | -0.9 | +10.1 |
Corporate actions
Upcoming
No upcoming corporate actions for NUS



